Toward a Rational Approach to Patent Ductus Arteriosus Trials: Selecting the Population of Interest

We read with interest the randomized trial report published by Roze et  al (the Targeted by echocardiographic tReatment Of the duCtus Arteriosus in Preterm Infants by Ibuprofen or TRIOCAPI Trial).1 This investigative group should be applauded for conducting a multi-institutional randomized trial with over 100 patients in each of the 3 groups. We would also like to exp ress our most sincere condolences to the investigative team regarding the untimely death of the principal investigator, Veronique Gournay, whose pioneering vision for this study in addition to her innovative patent ductus arteriosus (PDA) research should be recognized.

Source: The Journal of Pediatrics - January 9, 2021 Category: Pediatrics Authors: Afif El-Khuffash, Danielle R. Rios, Patrick J. McNamara Tags: Editorial Source Type: research